S 599

  • New York Senate Bill
  • 2023 Regular Session
  • Introduced in Senate
  • Passed Senate Jan 17, 2023
  • Assembly
  • Governor

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Votes


Actions


Jun 06, 2023

Senate

SUBSTITUTED BY A1707A

Jun 01, 2023

Senate

AMENDED ON THIRD READING 599A

Senate

VOTE RECONSIDERED - RESTORED TO THIRD READING

May 31, 2023

Assembly

RETURNED TO SENATE

Senate

RECALLED FROM ASSEMBLY

May 30, 2023

Assembly

RECOMMITTED TO HEALTH

Assembly

SUBSTITUTION RECONSIDERED

May 15, 2023

Assembly

ORDERED TO THIRD READING CAL.196

Assembly

SUBSTITUTED FOR A1707

Jan 17, 2023

Assembly

REFERRED TO HEALTH

Senate

DELIVERED TO ASSEMBLY

Senate

PASSED SENATE

Senate

ORDERED TO THIRD READING CAL.75

Senate

REPORTED AND COMMITTED TO RULES

Jan 05, 2023

Senate

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
S599 PDF HTML
S599A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.